Lanean...
A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties
INTRODUCTION: Activation of cyclooxygenase (COX)/prostaglandin and nuclear factor κB (NFκB) pathways can promote breast tumor initiation, growth, and progression to drug resistance and metastasis. Thus, anti-inflammatory drugs have been widely explored as chemopreventive and antineoplastic agents. A...
Gorde:
Argitaratua izan da: | BMC Cancer |
---|---|
Egile Nagusiak: | , , , , , |
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
BioMed Central
2015
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4632459/ https://ncbi.nlm.nih.gov/pubmed/26530254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1868-7 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|